Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
This grant opportunity supports early stage testing of new pharmacologic or device-based interventions to treat symptoms in individuals with mental illnesses such as schizophrenia, depression, autism, OCD, anxiety, and bipolar disorder. It encourages studies that intervene early when symptoms first appear, even if full diagnostic criteria are not yet met. The aim is to evaluate these intervent…
In the last several years, pharmaceutical companies have shifted their focus away from psychiatric indications due to the high failure rate of drug approvals, with many of the failures occurring in late-stage development after significant funding and testing had occurred. Likewise, a handful of …
Funding Source
Awards & funding
Eligibility
- Foreign eligibility: Non-domestic (non-U.S.) entities (foreign organizations) are eligible to apply. Non-domestic components of U.S. organizations are eligible. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Required registrations (must be complete…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers